Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer

In this study we sought to investigate the prevalence and prognostic value of androgen receptor (AR) status in operable triple-negative breast cancer (TNBC) patients. We collected the clinical data of 360 patients with TNBC, and found a positivity AR expression of 31.4% with a cut-off value of 10%....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiao-Qing, Chen, Wei-Li, Ma, Hai-Guang, Jiang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593567/
https://www.ncbi.nlm.nih.gov/pubmed/28915596
http://dx.doi.org/10.18632/oncotarget.16913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593567/
https://www.ncbi.nlm.nih.gov/pubmed/28915596
http://dx.doi.org/10.18632/oncotarget.16913

Ejemplares similares